🏛️ Verified NIH Record • Updated 2026-08-14

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2) (NCT07359846)

🟢 Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: Generate Biomedicines

🩺 Plain-English Summary (8th-Grade Level)

The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma that is uncontrolled by inhaled corticosteroids (ICS) and conventional asthma controllers. The study details include: Study treatment: randomized to receive either GB-0895 or placebo administered every 6 months over 52 weeks. Visit frequency: every 1-2 months after the first month.

Who can join: Review the eligibility criteria below.

Location: Research Site 13 — Bakersfield, California

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (68 Sites)

  • Research Site 13 — Bakersfield, California
  • Research Site 12 — Inglewood, California
  • Research Site 65 — Lancaster, California
  • Research Site 10 — West Covina, California
  • Research Site 06 — Miami, Florida
  • Research Site 03 — Miami, Florida
  • Research 09 — Orlando, Florida
  • Research Site 01 — Tamarac, Florida
  • Research Site 04 — Tampa, Florida
  • Research Site 05 — Tampa, Florida
  • Research Site 20 — Fall River, Massachusetts
  • Research Site 02 — Ypsilanti, Michigan
  • Research Site 69 — New York, New York
  • Research Site 11 — Dayton, Ohio
  • Research Site 21 — Oklahoma City, Oklahoma
  • Research Site 16 — Rock Hill, South Carolina
  • Research Site 17 — San Antonio, Texas
  • Research Site 07 — Sugar Land, Texas
  • Research Site 08 — Williamsburg, Virginia
  • Research Site 31 — Ciudad Autónoma de Buenos Aires, Buenos Aires
  • Research Site 33 — Ciudad Autónoma de Buenos Aires, Buenos Aires
  • Research Site 67 — Buenos Aires, Buenos Aires F.D.
  • Research site 39 — Southport, Queensland
  • Research Site 22 — Mechelen, Vlaams Brabant
  • Research Site 45 — Erpent,

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
🏛️ View Official NIH Record ↗